Sinopharm Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 80

  • Portfolio
  • 45

  • Exits
  • 26

Exits

Sinopharm Capital General Information

Company Description

Founded in 2012, Sinopharm Capital is a venture capital arm of Sinopharm Group based in Shanghai, China. The firm prefers to invest in the healthcare, life science, and biotechnology sectors.

Business Details

Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 16th Floor, Shen Building
  • Number 266 Hankou Road, Huangpu District
  • Shanghai, 200001
  • China

Sinopharm Capital Investments (80)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ray Everest 23-Aug-2023 Early Stage VC Discovery Tools (Healthcare) Generating Revenue
Longwell (Medical Robotics) 01-Sep-2022 Laboratory Services (Healthcare) Generating Revenue
AstraBio (China) 29-Jun-2022 Diagnostic Equipment Generating Revenue
OriCell Therapeutics 09-Jun-2022 Drug Discovery Generating Revenue
Artivila Therapeutics 31-Mar-2022 Drug Discovery Generating Revenue
MetaNovas Biotech 31-Mar-2022 Biotechnology Generating Revenue
CytoNiche 03-Mar-2022 Discovery Tools (Healthcare) Generating Revenue
Singlomics 14-Feb-2022 Drug Discovery Clinical Trials - Phase 2
Sumgen 29-Dec-2021 Later Stage VC Drug Discovery Generating Revenue
Longwell (Medical Robotics) 24-Nov-2021 Early Stage VC Laboratory Services (Healthcare) Generating Revenue
You’re viewing 10 of 80 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinopharm Capital Exits (26)

Company Name Exit Date Exit Type Exit Size
Kira Pharma 16-Jul-2026 Merger/Acquisition
Ray Everest 23-Jun-2026
Virogin Biotech 01-Jun-2026
AND Technology 10-Feb-2026
Genfleet 19-Sep-2025
Kanglu Bio 05-Aug-2025
Suzhou Sepax Technologies 10-Jan-2025
YesSkin 31-Oct-2024
ECCOGENE 24-Jan-2024 Secondary Transaction - Private
ECCOGENE 08-Jan-2024 Secondary Transaction - Private
You’re viewing 10 of 26 exits. Get the full list »

Sinopharm Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sinopharm Capital FAQs

  • What is Sinopharm Capital?

    Founded in 2012, Sinopharm Capital is a venture capital arm of Sinopharm Group based in Shanghai, China.

  • When was Sinopharm Capital founded?

    Sinopharm Capital was founded in 2012.

  • Where is Sinopharm Capital headquartered?

    Sinopharm Capital is headquartered in Shanghai, China.

  • How many investments has Sinopharm Capital made?

    Sinopharm Capital has made 80 investments.

  • What has Sinopharm Capital invested in?

    Sinopharm Capital has made numerous investments in companies like Ray Everest, Longwell (Medical Robotics), and AstraBio (China) within the Discovery Tools (Healthcare), Laboratory Services (Healthcare), and Diagnostic Equipment industries.

  • What has Sinopharm Capital invested in recently?

    Sinopharm Capital's latest investment was on 23-Aug-2023 in Ray Everest, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process